Clinical significance of tissue polypeptide antigen in serum of acute nonlymphocytic leukemia

Leuk Res. 1995 Jun;19(6):407-9. doi: 10.1016/0145-2126(95)00006-a.

Abstract

Tissue polypeptide antigen (TPA) in serum was measured at diagnosis in 27 patients with acute nonlymphocytic leukemia (ANLL) (1 FAB M0, 1 M1, 10 M2, 7 M3, 5 M4, 1 M5, 1 M6 and 1 MU). Statistical analysis disclosed a close correlation of TPA level with age (P < 0.01), hemoglobin level (P < 0.05), therapeutic response (P < 0.01) and the length of survival after the initial diagnosis (P < 0.02). A significant difference in TPA level was present between patients with complete remission and those with poor response. To our knowledge, this is the first report to prove a correlation of TPA level with therapeutic response and the length of survival in ANLL.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antigens, Neoplasm / blood*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor / blood*
  • Bone Marrow Cells
  • Female
  • Hemoglobins / metabolism
  • Humans
  • Leukemia, Myeloid, Acute / blood*
  • Leukemia, Myeloid, Acute / drug therapy
  • Male
  • Middle Aged
  • Peptides / blood*
  • Platelet Count
  • Predictive Value of Tests
  • Prognosis
  • Reference Values
  • Tissue Polypeptide Antigen
  • Treatment Outcome

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Hemoglobins
  • Peptides
  • Tissue Polypeptide Antigen